Similar results have been reported in systemic lupus erythematosus (SLE) and IgG4-related diseases, emphasizing the potential of plasmablast surveillance to evaluate disease activity, which may be linked to BLyS and APRIL levels (50–53). The gene discussed is TNFSF13; the disease is systemic lupus erythematosus.